Cvs Health (CVS) Cash from Financing Activities (2009 - 2026)

Cvs Health (CVS) has 18 years of Cash from Financing Activities data on file, last reported at -$2.3 billion in Q1 2026.

• Quarterly Cash from Financing Activities rose 0.6% year-over-year to -$2.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.9 billion (down 119.91% YoY) and the FY2025 annual result came in at -$4.9 billion, down 335.24% from the prior year.
• Cash from Financing Activities slipped to -$2.3 billion in Q1 2026, from -$2.0 billion in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $3.6 billion in Q2 2023 to a low of -$3.2 billion in Q3 2022.
• A 5-year average of -$954.5 million and a median of -$1.6 billion in 2024 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities jumped 247.34% — and 2025, when it slumped 571.46%.
• Tracing CVS's Cash from Financing Activities over 5 years: stood at -$2.2 billion in 2022, then surged by 55.56% to -$972.0 million in 2023, then soared by 144.34% to $431.0 million in 2024, then tumbled by 571.46% to -$2.0 billion in 2025, then decreased by 14.07% to -$2.3 billion in 2026.
• The last three Cash from Financing Activities figures came in at -$2.3 billion (Q1 2026), -$2.0 billion (Q4 2025), and -$1.4 billion (Q3 2025), per Business Quant data.